Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

被引：28
|
作者：
Huiberts, Anne J. [1 ]
de Gier, Brechje [1 ]
Hoeve, Christina E. [1 ]
de Melker, Hester E. [1 ]
Hahne, Susan J. M. [1 ]
den Hartog, Gerco [1 ,2 ]
van de Wijgert, Janneke H. H. M. [1 ,3 ]
van den Hof, Susan [1 ]
Knol, Mirjam J. [1 ]
机构：
[1] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
[2] Radboudumc, Radboud Ctr Infect Dis, Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
EUROSURVEILLANCE | 2023年 / 28卷 / 07期
关键词：
D O I：
10.2807/1560-7917.ES.2023.28.7.2300087
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We used data of 32,542 prospective cohort study participants who previously received primary and one or two monovalent booster COVID-19 vaccinations. Between 26 September and 19 December 2022, relative effectiveness of bivalent original/Omicron BA.1 vaccination against self-reported Omicron SARS-CoV-2 infection was 31% in 18- 59-year-olds and 14% in 60- 85-year-olds. Protection of Omicron infection was higher than of bivalent vaccination without prior infection. Although bivalent booster vaccination increases protection against COVID- 19 hospitalisations, we found limited added benefit in preventing SARS-CoV-2 infection.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens
    Mai-Chi Trieu
    Arnold Reynaldi
    Wen Shi Lee
    Hyon-Xhi Tan
    Andrew Kelly
    Robyn Esterbauer
    Rebecca J. Cox
    Jennifer Audsley
    Joseph Sasadeusz
    David S. Khoury
    Miles P. Davenport
    Deborah Cromer
    Adam K. Wheatley
    Stephen J. Kent
    Jennifer A. Juno
    npj Vaccines, 10 (1)
  • [22] Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
    Muller, Thomas R. R.
    Sekine, Takuya
    Trubach, Darya
    Niessl, Julia
    Chen, Puran
    Bergman, Peter
    Blennow, Ola
    Hansson, Lotta
    Mielke, Stephan
    Nowak, Piotr
    Vesterbacka, Jan
    Akber, Mira
    Olofsson, Anna
    Hernandez, Susana Patricia Amaya
    Gao, Yu
    Cai, Curtis
    Soderdahl, Gunnar
    Smith, C. I. Edvard
    Osterborg, Anders
    Lore, Karin
    Sallberg Chen, Margaret
    Ljungman, Per
    Ljunggren, Hans-Gustaf
    Karlsson, Annika C. C.
    Saini, Sunil Kumar
    Aleman, Soo
    Buggert, Marcus
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (704)
  • [23] SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
    Bloomfield, Lauren E.
    Ngeh, Sera
    Cadby, Gemma
    Hutcheon, Kate
    Effler, Paul V.
    EMERGING INFECTIOUS DISEASES, 2023, 29 (06) : 1162 - 1172
  • [24] Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review
    Du, Yuxuan
    Chen, Long
    Shi, Yuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [25] Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection
    Wald, Anna
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 327 - 328
  • [26] Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
    Abu-Raddad, L. J.
    Chemaitelly, H.
    Ayoub, H. H.
    AlMukdad, S.
    Yassine, H. M.
    Al-Khatib, H. A.
    Smatti, M. K.
    Tang, P.
    Hasan, M. R.
    Coyle, P.
    Al-Kanaani, Z.
    Al-Kuwari, E.
    Jeremijenko, A.
    Kaleeckal, A. H.
    Latif, A. N.
    Shaik, R. M.
    Abdul-Rahim, H. F.
    Nasrallah, G. K.
    Al-Kuwari, M. G.
    Butt, A. A.
    Al-Romaihi, H. E.
    Al-Thani, M. H.
    Al-Khal, A.
    Bertollini, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19): : 1804 - 1816
  • [27] Effectiveness of Booster mRNA Vaccines Against SARS-CoV-2 Infection in an Elderly Population, South Korea, October 2021-January 2022
    Kim, Jia
    Choe, Young June
    Jang, Eun Jung
    Lim, Do Sang
    Kim, Yoo Yeon
    Kim, Ryu Kyung
    Yi, Seonju
    Lee, Sangwon
    Park, Young Joon
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (05) : 920 - 921
  • [28] Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection
    Jang, Eun Jung
    Choe, Young June
    Kim, Ryu Kyung
    Lee, Sangwon
    Park, Seon Kyeong
    Park, Young-Joon
    JAMA NETWORK OPEN, 2023, 6 (03) : E232578
  • [29] Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
    He, Xiaofeng
    Zeng, Biao
    Wang, Ye
    Pang, Yulian
    Zhang, Meng
    Hu, Ting
    Liang, Yuanhao
    Kang, Min
    Tang, Shixing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts
    Liu, Di
    Feng, Siyang
    Sha, Feng
    Liao, Yuxue
    Xie, Xu
    Huang, Fang
    Kong, Dongfeng
    Zhang, Zhen
    Chen, Zhigao
    Chen, Nixuan
    Gao, Wei
    Feng, Tiejian
    Zhao, Ziyi
    Li, Bingli
    Li, Ying
    Zhu, Fengcai
    Yang, Zhirong
    Lv, Qiuying
    Feng, Zijian
    Tang, Jinling
    JAMA NETWORK OPEN, 2023, 6 (10) : E2339507
12345